NYSE American - Delayed Quote USD

Myomo, Inc. (MYO)

Compare
3.7600 -0.0100 (-0.27%)
At close: October 25 at 4:00 PM EDT
3.7400 -0.02 (-0.53%)
After hours: October 25 at 7:51 PM EDT

Key Executives

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Mr. Paul R. Gudonis Chairman, President & CEO 526.56k -- 1955
Mr. David A. Henry Chief Financial Officer 401.56k -- 1961
Dr. Harry Kovelman M.D. Chief Medical Officer 426.03k -- 1959
Colin Anderson Global Director of Operations -- -- --
Mr. Joseph Chicoskie Director of Marketing -- -- --
Ms. Galina Shtivelman Senior Director of Human Resources -- -- --
Mr. Micah J. Mitchell Chief Commercial Officer 317.39k -- 1976

Myomo, Inc.

137 Portland Street
4th Floor
Boston, MA 02114
United States
617-996-9058 https://myomo.com
Sector:?
Healthcare
Industry:?
Medical Devices
Full Time Employees:?
101

Description

Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, China, Germany, and internationally. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living. It also provides the MyoPro 2, including control technology, configuration software and user interface, and pop-out battery for extended use of the brace; and MyoPro2+ that comprises 3D printed orthotics capability, software enhancements, and a design for donning and doffing of the device. Its products are designed to help improve function in adults and adolescents with neuromuscular conditions due to brachial plexus injury, stroke, traumatic brain injury, spinal cord injury, and other neurological disorders. The company sells its products through various sales channels, including orthotics and prosthetics providers, the Veterans Administration, and its distributors. Myomo, Inc. was incorporated in 2004 and is headquartered in Boston, Massachusetts.

Corporate Governance

Myomo, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

November 5, 2024 at 10:59 AM UTC - November 11, 2024 at 12:00 PM UTC

Myomo, Inc. Earnings Date

Recent Events

August 26, 2024 at 12:00 AM UTC

CORRESP: A correspondence can be sent as a document with another submission type or can be sent as a separate submission

August 13, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

August 6, 2024 at 8:30 PM UTC

Q2 2024 Earnings Call

August 6, 2024 at 12:00 AM UTC

10-Q: Periodic Financial Reports

July 15, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

July 8, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

June 7, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

May 30, 2024 at 12:00 AM UTC

SD: Specialized Disclosure Report filed pursuant to Section 1502 of the Dodd-Frank Wall Street Reform and Consumer Protection Act relating to the use of conflict minerals (Rule 13p-1)

May 8, 2024 at 12:00 AM UTC

10-Q: Periodic Financial Reports

May 6, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

Related Tickers